Bioelectronics Corp (BIEL)

[GetSeriousOK]

I asked CoPilot your exact question TWICE. The answer I got is legitimate because it identifies the problem with BIEL's survey: The survey only asked followup questions about all analgesics grouped together, INCLUDING opioids, not about opioids alone, which means the CMS won't accept it for the NOPAIN Act:

Sent by you:
is there clinical study data showing that Actipatch can reduce the use of opioids?

Copilot
Yes, there is some data suggesting that ActiPatch, a pulsed shortwave therapy device, can help reduce the use of opioids. A survey conducted by BioElectronics found that a significant number of ActiPatch users reported a marked decrease in their use of systemic analgesic pain medications, including opioids1.

Additionally, ActiPatch has been shown to be effective in managing chronic pain, which can potentially reduce the need for opioid medications23. However, it’s important to note that while these findings are promising, more extensive clinical trials would be beneficial to further validate these results.

Would you like more detailed information on how ActiPatch works or its other benefits?

Second time, the CoPilot answer to your exact question:

Yes, there is some clinical data suggesting that ActiPatch can help reduce the use of opioids. A survey conducted by BioElectronics found that a significant number of ActiPatch users reported a marked decrease in their use of systemic analgesic pain medications, including opioids1.

Additionally, a study published in the Indian Journal of Palliative Care discussed the potential of ActiPatch as an opioid-free, medication-free treatment modality for chronic pain management2. While these findings are promising, more extensive clinical trials would be beneficial to further validate these results.

Would you like more detailed information on how ActiPatch works or its other benefits?

Incidentally, that 76% opioid number in BIEL's marketing piece is not something they can submit to the CMS. It comes from this article that CoPilot found:

https://www.bielcorp.com/actipatch-survey-chronic-pain-management-decrease-opioid-use/

The CMS won't accept that. Here is the published journal article for that survey -- this is the "evidence" that BIEL would have to submit to the CMS. There is nothing in this article about opioid reduction. -- nothing about "those taking opioids pain drugs alone."

https://onlinelibrary.wiley.com/doi/10.1155/2019/3154194

Table 3 shows the data they collected of analgesics used BEFORE the ActiPatch.

If you read the actual survey, you'll see that they collected this detail about PREVIOUS analgesic use but there were no questions about opioid use AFTER using the ActiPatch -- the survey questions about AFTER use were about analgesic reduction all lumped together and they didn't include that in their journal article so the CMS won't see even THAT.

BTW your word "CHALLANGE" is a puzzling mis-spelling. Why did you type it in all caps and bold it if you don't know how the word is spelled? I would think that someone who claims to have only 1/4 brain would use a spell checker. 😁